Published in Ophthalmology on March 01, 1999
Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication. Br J Ophthalmol (2002) 2.67
German register for glaucoma patients with dry eye. I. Basic outcome with respect to dry eye. Graefes Arch Clin Exp Ophthalmol (2008) 1.85
Conjunctival and corneal reactions in rabbits following short- and repeated exposure to preservative-free tafluprost, commercially available latanoprost and 0.02% benzalkonium chloride. Br J Ophthalmol (2008) 1.50
Intensified postoperative care versus conventional follow-up: a retrospective long-term analysis of 177 trabeculectomies. Graefes Arch Clin Exp Ophthalmol (2003) 1.23
In vitro effects of preserved and unpreserved antiglaucoma drugs on apoptotic marker expression by human trabecular cells. Graefes Arch Clin Exp Ophthalmol (2003) 1.15
Travoprost 0.004%/timolol 0.5%-fixed combination with and without benzalkonium chloride: a prospective, randomized, doubled-masked comparison of safety and efficacy. Eye (Lond) (2011) 0.99
Comparison of diagnostic tests in distinct well-defined conditions related to dry eye disease. PLoS One (2014) 0.98
How ocular surface disease impacts the glaucoma treatment outcome. Biomed Res Int (2013) 0.94
The effect of previous surgery and topical eye drops for primary open-angle glaucoma on cytokine expression in aqueous humor. Graefes Arch Clin Exp Ophthalmol (2014) 0.90
Graft failure: III. Glaucoma escalation after penetrating keratoplasty. Int Ophthalmol (2008) 0.89
Inflammatory molecules in aqueous humour and on ocular surface and glaucoma surgery outcome. Mediators Inflamm (2010) 0.88
Adult keratoplasty: has the prognosis improved in the last 25 years? Int Ophthalmol (2008) 0.88
Irreversible electroporation for microbial control of drugs in solution. AAPS PharmSciTech (2009) 0.87
Lyophilisates for drug delivery in ophthalmology: pharmacokinetics of fluorescein in the human anterior segment. Br J Ophthalmol (2002) 0.85
Challenges in the clinical measurement of ocular surface disease in glaucoma patients. Clin Ophthalmol (2011) 0.85
In vitro and in vivo experimental studies on trabecular meshwork degeneration induced by benzalkonium chloride (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc (2012) 0.85
Multiple endpoint analysis of BAC-preserved and unpreserved antiallergic eye drops on a 3D-reconstituted corneal epithelial model. Mol Vis (2011) 0.85
Confocal microscopic examination of trabecular meshwork removed during ab externo trabeculectomy. Br J Ophthalmol (2002) 0.85
Characteristics of uveitic glaucoma and evaluation of its surgical treatment. Clin Ophthalmol (2014) 0.85
Effects of benzalkonium chloride on THP-1 differentiated macrophages in vitro. PLoS One (2013) 0.84
Glaucoma therapy escalation in eyes with pseudophakic corneal edema after penetrating keratoplasty and Descemet's stripping automated endothelial keratoplasty. Int Ophthalmol (2012) 0.83
Benzalkonium chloride and glaucoma. J Ocul Pharmacol Ther (2013) 0.82
Trefoil factor family 1, MUC5AC and human leucocyte antigen-DR expression by conjunctival cells in patients with glaucoma treated with chronic drugs: could these markers predict the success of glaucoma surgery? Br J Ophthalmol (2006) 0.82
Ocular surface alterations and topical antiglaucomatous therapy: a review. Open Ophthalmol J (2014) 0.79
Effects of aqueous instillation. Ophthalmology (1999) 0.78
Efficacy and patient tolerability of travoprost BAK-free solution in patients with open-angle glaucoma and ocular hypertension. Clin Ophthalmol (2010) 0.77
In Vivo Effects of Preservative-free and Preserved Prostaglandin Analogs: Mouse Ocular Surface Study. Korean J Ophthalmol (2015) 0.77
Benefits of switching from latanoprost to preservative-free tafluprost eye drops: a meta-analysis of two Phase IIIb clinical trials. Clin Ophthalmol (2016) 0.77
Effect of Korean Red Ginseng supplementation on dry eye syndrome in glaucoma patients - A randomized, double-blind, placebo-controlled study. J Ginseng Res (2014) 0.77
Effects of antiglaucoma drugs on the ocular surface in rabbits: a fixed-combination drug versus two concomitant drugs. Jpn J Ophthalmol (2011) 0.77
Safety and tolerability of tafluprost in treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension. Clin Ophthalmol (2010) 0.77
Glaukos iStent inject® Trabecular Micro-Bypass Implantation Associated with Cataract Surgery in Patients with Coexisting Cataract and Open-Angle Glaucoma or Ocular Hypertension: A Long-Term Study. J Ophthalmol (2016) 0.76
The tear fluid mucin 5AC change of primary angle-closure glaucoma patients after short-term medications and phacotrabeculectomy. Mol Vis (2010) 0.76
Effect of 0.3% Hydroxypropyl Methylcellulose/Dextran Versus 0.18% Sodium Hyaluronate in the Treatment of Ocular Surface Disease in Glaucoma Patients: A Randomized, Double-Blind, and Controlled Study. J Ocul Pharmacol Ther (2015) 0.76
[Glaucoma and corneal transplantation]. Ophthalmologe (2010) 0.75
Personalized Medicine in Ophthalmology: From Pharmacogenetic Biomarkers to Therapeutic and Dosage Optimization. J Pers Med (2013) 0.75
Conjunctival changes and inflammatory aspects in rabbits' conjunctivas induced by fixed combinations of prostaglandin analogues and timolol maleate. J Ophthalmic Inflamm Infect (2013) 0.75
Conjunctival markers as predictable markers for preoperative glaucoma assessment. Br J Ophthalmol (2006) 0.75
A Rare Case Report of Conjunctival Cyst. J Clin Diagn Res (2015) 0.75
Multiplex cytokine levels of aqueous humor in acute primary angle-closure patients: fellow eye comparison. BMC Ophthalmol (2016) 0.75
Antiglaucoma drugs: The role of preservative-free formulations. Saudi J Ophthalmol (2011) 0.75
Analysis of the effects of preservative-free tafluprost on the tear proteome. Am J Transl Res (2016) 0.75
Effects of Long-Term Antiglaucoma Eye Drops on Conjunctival Structures: An In Vivo Confocal Microscopy Study. J Ophthalmol (2015) 0.75
Comparison of the Anti-Inflammatory Effects of Artificial Tears in a Rat Model of Corneal Scraping. J Ocul Pharmacol Ther (2016) 0.75
Sphingosine-1 phosphate prevents ethanol-induced corneal epithelial apoptosis. Indian J Ophthalmol (2012) 0.75
Controversy: Is Benzalkonium Chloride Necessary in Antiglaucoma Drops? J Curr Glaucoma Pract (2012) 0.75
Therapeutic Effects of Sodium Hyaluronate on Ocular Surface Damage Induced by Benzalkonium Chloride Preserved Anti-glaucoma Medications. Chin Med J (Engl) (2015) 0.75
Effect of benzalkonium chloride-free latanoprost ophthalmic solution on ocular surface in patients with glaucoma. Clin Ophthalmol (2016) 0.75
[Preservatives from the perspective of glaucoma surgery]. Ophthalmologe (2012) 0.75
[Preoperative therapy switch before glaucoma filtration surgery : Influence of the systemic antiglaucomatous and local antiphlogistic therapy on the intraocular pressure]. Ophthalmologe (2016) 0.75
Recurrent mutations in a single exon encoding the evolutionarily conserved olfactomedin-homology domain of TIGR in familial open-angle glaucoma. Hum Mol Genet (1997) 2.08
Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes. Invest Ophthalmol Vis Sci (2000) 1.74
Quaternary ammoniums and other preservatives' contribution in oxidative stress and apoptosis on Chang conjunctival cells. Invest Ophthalmol Vis Sci (2001) 1.39
Comparison of the effects of preserved and unpreserved formulations of timolol on the ocular surface of albino rabbits. Ophthalmic Res (2000) 1.25
Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporin A. Invest Ophthalmol Vis Sci (2001) 1.20
Flow cytometry in impression cytology specimens. A new method for evaluation of conjunctival inflammation. Invest Ophthalmol Vis Sci (1997) 1.15
Association of a single nucleotide polymorphism in the TIGR/MYOCILIN gene promoter with the severity of primary open-angle glaucoma. Clin Genet (2001) 1.07
Mitochondrial activity and glutathione injury in apoptosis induced by unpreserved and preserved beta-blockers on Chang conjunctival cells. Invest Ophthalmol Vis Sci (2001) 1.03
Histopathological effects of topical ophthalmic preservatives on rat corneoconjunctival surface. Curr Eye Res (1998) 1.01
Expression of Fas-Fas ligand antigens and apoptotic marker APO2.7 by the human conjunctival epithelium. Positive correlation with class II HLA DR expression in inflammatory ocular surface disorders. Exp Eye Res (1998) 1.01
[The study of Touggourt, a proposition for the large scale discovery of chronic glaucoma by examination of the optic disc (author's transl)]. J Fr Ophtalmol (1980) 0.99
Bone mineral density in sixty adult patients with Marfan syndrome. Osteoporos Int (1999) 0.97
[Particularly rapid appearance of a severe toxic keratopathy caused by oxybuprocaine]. Bull Soc Ophtalmol Fr (1981) 0.97
Differential regulation of inducible nitric oxide synthase by fibroblast growth factors and transforming growth factor beta in bovine retinal pigmented epithelial cells: inverse correlation with cellular proliferation. Proc Natl Acad Sci U S A (1993) 0.94
Riluzole improves functional recovery after ischemia in the rat retina. Invest Ophthalmol Vis Sci (1999) 0.92
[Severe bilateral capsulorhexis contraction after cataract surgery in myotonic dystrophy: a case report]. J Fr Ophtalmol (2004) 0.91
Correlation between tear IgE levels and HLA-DR expression by conjunctival cells in allergic and nonallergic chronic conjunctivitis. Graefes Arch Clin Exp Ophthalmol (2000) 0.90
[Linkage between juvenile glaucoma and chromosome 1q in 2 French families]. C R Acad Sci III (1994) 0.90
Genetic heterogeneity of primary open angle glaucoma and ocular hypertension: linkage to GLC1A associated with an increased risk of severe glaucomatous optic neuropathy. J Med Genet (1997) 0.90
Inflammation measurement and immunocharacterization of cell proliferation in an experimental model of proliferative vitreoretinopathy. Ophthalmic Res (1998) 0.88
Follow up by colour Doppler imaging of 102 patients with retinal vein occlusion over 1 year. Br J Ophthalmol (2002) 0.88
Protection against light-induced retinal degeneration by an inhibitor of NO synthase. Neuroreport (1993) 0.87
Human eyelash characterization. Br J Dermatol (2009) 0.85
[Clinical tolerance of antiglaucoma eyedrops with and without a preservative. Results of an unpublished survey in Europe]. J Fr Ophtalmol (1999) 0.85
[Long-chain 3-hydroxyacyl CoA dehydrogenase deficiency and choroidal neovascularization]. J Fr Ophtalmol (2008) 0.84
Age-dependent penetrance and mapping of the locus for juvenile and early-onset open-angle glaucoma on chromosome 1q (GLC1A) in a French family. Hum Genet (1996) 0.84
[Cytomegalovirus retinitis and ocular complications in AIDS patients in Togo]. J Fr Ophtalmol (1999) 0.84
Marfan syndrome and fibrillin disorders. Joint Bone Spine (2000) 0.83
[Use of the adhesive isobutyl-2-cyanoacrylate in the treatment of external fistulas after trabeculectomy; apropos of 2 cases]. Bull Soc Ophtalmol Fr (1978) 0.83
[Contribution of nidus fluorescence in the surgical treatment of osteoid osteoma. Apropos of 17 cases]. Rev Chir Orthop Reparatrice Appar Mot (1996) 0.82
[Radial optic neurotomy for severe central retinal vein occlusion: preliminary results]. J Fr Ophtalmol (2003) 0.82
[A rare complication of ophthalmic zona: scleral perforation with hernia of the ciliary body]. Bull Soc Ophtalmol Fr (1977) 0.81
[Congenital ectropion of the iris epithelium and glaucoma]. J Fr Ophtalmol (1985) 0.80
Extensive brain calcification in two children with bilateral Coats' disease. Neuropediatrics (1999) 0.80
[The lipid layer of the lacrimal tear film: physiology and pathology]. J Fr Ophtalmol (2001) 0.79
Immunophenotyping of human dendriform cells from the conjunctival epithelium. Curr Eye Res (1997) 0.79
[Evaluation of free radical production by conjunctival impression cytology of patients treated with long-term antiglaucoma drugs or of contact lens wearers]. J Fr Ophtalmol (2000) 0.79
[Facial hemangioma associated with arterial anomalies, coarctation of the aorta, and eye abnormalities: PHACES syndrome]. Ann Dermatol Venereol (2000) 0.79
[Data bank for analysis of the normal visual field using the 30/1 central program of the automated Humphrey perimeter]. J Fr Ophtalmol (1986) 0.79
[Quaternary ammonium cytotoxicity in a human conjunctival cell line]. J Fr Ophtalmol (1999) 0.78
[Triamcinolone-assisted vitrectomy in the treatment of recurrent retinal detachment due to myopic macular hole]. J Fr Ophtalmol (2006) 0.78
[Positive diagnosis of Leber's hereditary optic neuropathy using molecular genetics]. J Fr Ophtalmol (1997) 0.78
[Cytotoxicity evaluation of three tear substitutes used in the treatment of dry eye syndromes]. J Fr Ophtalmol (2000) 0.77
Effects of EGb761 and superoxide dismutase in an experimental model of retinopathy generated by intravitreal production of superoxide anion radical. Graefes Arch Clin Exp Ophthalmol (1999) 0.77
[Clinical features of gliomas of the chiasma. A retrospective study of a series of 18 patients]. J Fr Ophtalmol (2000) 0.77
[Corneal stromal changes after LASIK]. J Fr Ophtalmol (2002) 0.76
[Flow cytometry in impression cytology during keratoconjunctivitis sicca: effects of topical cyclosporin A on HLA DR expression]. J Fr Ophtalmol (2003) 0.76
[Congenital anterior megalophthalmos]. Bull Soc Ophtalmol Fr (1976) 0.76
[Evaluation by laser flare meter of the inflammatory response after cataract surgery]. J Fr Ophtalmol (1998) 0.75
[Deep sclerectomy in congenital glaucoma. Preliminary results]. J Fr Ophtalmol (1999) 0.75
[Antioxidant effects of mast cell inhibitors in a human conjunctival cell line]. J Fr Ophtalmol (2001) 0.75
[Graft of pigment epithelium: past, present and future]. Bull Soc Belge Ophtalmol (1993) 0.75
[Precipitation of closure of the angle]. Bull Mem Soc Fr Ophtalmol (1977) 0.75
[A new experimental route of approach to Schlemm's canal]. Bull Soc Ophtalmol Fr (1979) 0.75
[Retina]. J Fr Ophtalmol (1999) 0.75
[Role of vitrectomy in the treatment of retinal arterial macroaneurysms]. J Fr Ophtalmol (1999) 0.75
[Traumatic stimulation of the prostaglandin synthetase systems of the eye. Therapeutic importance]. Bull Mem Soc Fr Ophtalmol (1976) 0.75
[Value of multidisciplinary consultation in diagnosis and survival of Marfan syndrome]. Presse Med (1998) 0.75
[Immunophenotype of dendritic cells of the human conjunctiva]. J Fr Ophtalmol (1996) 0.75
[Suturing of corneal wounds with monofilament]. Bull Soc Ophtalmol Fr (1976) 0.75
[Surgery of collapse of Schlemm's canal in the treatment of glaucoma; current status and prospects]. Bull Soc Ophtalmol Fr (1978) 0.75
[Time study of the growth of 30 ametropic eyes in adolescents]. Ann Ocul (Paris) (1972) 0.75
[Color Doppler ultrasonography of short para-optic ciliary arteries in vascular glaucoma]. J Fr Ophtalmol (1999) 0.75
[Local indomethacin and early postcontusive ocular reaction in rabbits]. Arch Ophtalmol (Paris) (1976) 0.75
[Technic of aspiration-discission of traumatic cataract in adults, using the double-current catheter]. Bull Soc Ophtalmol Fr (1977) 0.75
[beta-blockers via general route, chronic glaucoma and arterial hypertension]. Bull Soc Ophtalmol Fr (1978) 0.75
[Presentation of an automatic device for reading the Farnsworth 100 hue test]. Bull Soc Ophtalmol Fr (1978) 0.75
[Course of epithelial scars after surgical removal of small-size subfoveal neovessels]. J Fr Ophtalmol (1999) 0.75
[Leplat's reaction and prostaglandins: an angiographic study of the anterior segment in rabbits]. Bull Soc Belge Ophtalmol (1977) 0.75
[Dry eye syndromes and the ocular surface]. J Fr Ophtalmol (1999) 0.75
[Multifocal placoid epitheliopathy and anti-hepatitis B vaccination]. J Fr Ophtalmol (1998) 0.75
[Persistence of the pupillary membrane. Apropos of 3 cases]. J Fr Ophtalmol (1999) 0.75
[Retinal degeneration]. J Fr Ophtalmol (2000) 0.75
[Value of lacrymal IgE determination and conjunctival cytology in the diagnosis of chronic conjunctivitis]. J Fr Ophtalmol (1998) 0.75
[Apoptosis and the eye. Review of the literature]. J Fr Ophtalmol (1997) 0.75
[Creating a specific quality-of-life questionnaire in patients with glaucoma: item generation]. J Fr Ophtalmol (2002) 0.75
[Main mechanisms of kerato-conjunctival inflammation]. J Fr Ophtalmol (1997) 0.75
[Examination of the fundus oculi in the acute phase of Leber's hereditary optic neuritis]. Bull Soc Ophtalmol Fr (1975) 0.75
[Clinical exploration of the lipid phase of the laryngeal film using Tearscdope plus]. J Fr Ophtalmol (1999) 0.75
[Microsurgery of glaucoma]. Bull Soc Ophtalmol Fr (1976) 0.75
[Human onchocerciasis and "sowda" in the Republic of Yemen]. Bull Acad Natl Med (2001) 0.75
[Do parenterally administered anti-prostaglandins have an action on the ocular pressure?]. Bull Soc Ophtalmol Fr (1972) 0.75
[Possible role of a metal deficiency in the pathogenesis of various forms of toxic and nutritional optic neuritis]. Bull Mem Soc Fr Ophtalmol (1976) 0.75
[2 years of cryopexy in the treatment of idiopathic retinal detachment]. Bull Soc Ophtalmol Fr (1973) 0.75
[Freeing of the ciliary body in the treatment of severe secondary glaucoma--2 methods derived from Benedikt's technic]. Bull Soc Ophtalmol Fr (1978) 0.75
[Drug induced optic neuritis]. Annee Ther Clin Ophtalmol (1976) 0.75
[Optic neuritis caused by ethambutol]. Bull Mem Soc Fr Ophtalmol (1973) 0.75